European Natural Food & Trading Co, Inc. of Paterson, NJ is recalling Brian’s Cauliflower 83 oz. due to undeclared sulfites. People who have an allergy or severe sensitivity to sulfites run the risk of serious or life-threatening allergic reaction if they consume these products.
Category Archives: Food & Drug Recalls
Braga Organic Farms Issues Voluntary Recall of Pistachios Due to Possible Health Risk
Braga Organic Farms announces the voluntary recall of pistachios due to potential contamination with Salmonella, an organism that can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with Salmonella can experience fever, diarrhea (which may be bloody), nausea, vomiting, and abdominal pain.
Garden of Life, LLC Recalls Raw Meal Organic Shake & Meal Products Because of Possible Health Risk
Garden of Life LLC is voluntarily withdrawing a limited quantity of its Raw Meal Organic Shake & Meal Chocolate, Original, Vanilla and Vanilla Chai because they have the potential to contain Salmonella Virchow. Even though Garden of Life routinely performs pathogen testing on every finished good lot to ensure safety and no product has ever tested positive for the presence of Salmonella, the company felt it was in the public’s best interest to take this voluntary action.
Lucy’s Weight Loss System Issues Voluntary Nationwide Recall of Pink Bikini and Shorts on The Beach Dietary Supplements Due To Possible Undeclared Active Pharmaceutical Ingredient
Lucy’s Weight Loss System is voluntarily recalling all lots of Pink Bikini and Shorts on the Beach Capsules in all colors, 30 count (750MG per capsule) to the consumer level. Pink Bikini and Shorts on the Beach may contain an undeclared active pharmaceutical ingredient.
FDA approves Zepatier for treatment of chronic hepatitis C genotypes 1 and 4
The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.
FDA approves first drug to show survival benefit in liposarcoma
The U.S. Food and Drug Administration today approved Halaven (eribulin mesylate), a type of chemotherapy, for the treatment of liposarcoma (a specific type of soft tissue sarcoma) that cannot be removed by surgery (unresectable) or is advanced (metastatic). This treatment is approved for patients who received prior chemotherapy that contained an anthracycline drug.
House of Flavors Issues Allergy Alert on Undeclared Pecans in Purple Cow Cookie Butter Ice Cream
House of Flavors, Inc. is voluntarily recalling a small batch of 8 oz. cups of Purple Cow Limited Edition Cookie Butter Ice Cream, sold at Meijer stores, that contain Purple Cow Butter Pecan Ice Cream with a Purple Cow Butter Pecan lid. Consumers who may have a severe allergy or sensitivity to nuts run the risk of potentially life-threatening allergic reaction if they consume this product.
House of Flavors Issues Allergy Alert on Undeclared Pecans in Purple Cow Cookie Butter Ice Cream
House of Flavors, Inc. is voluntarily recalling a small batch of 8 oz. cups of Purple Cow Limited Edition Cookie Butter Ice Cream, sold at Meijer stores, that contain Purple Cow Butter Pecan Ice Cream with a Purple Cow Butter Pecan lid. Consumers who may have a severe allergy or sensitivity to nuts run the risk of potentially life-threatening allergic reaction if they consume this product.
Figi’s Issues Recall Alert on Mislabeled Marzipan
Figi’s Companies, Inc. of Marshfield, WI is recalling 8 ounce packages of “Classic Marzipan” because the ingredients are not properly labeled and the product contains undeclared almonds. People who have allergies to almonds run the risk of serious or life-threatening allergic reaction if they consume these products.
FDA Classifies St. Jude Medical Field Action For 447 Of The Company’s Optisure High Voltage Leads As A Class 1 Advisory In The U.S.
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that a previously communicated voluntary global field safety action related to the company’s Optisure™ Dual Coil Defibrillation Leads has now been classified as a Class 1 Advisory by the U.S. Food and Drug Administration. The Class 1 Advisory relates to a limited and well-defined group of 447 Optisure leads, 278 of which were distributed in the U.S., which may have been damaged during a manufacturing step.